STATEMENT BY
BRIGADIER GENERAL STEPHEN V. REEVES
PROGRAM EXECUTIVE OFFICER
FOR THE CHEMICAL AND BIOLOGICAL DEFENSE
PROGRAM
BEFORE THE SUBCOMMITTEE
ON TERRORISM, UNCONVENTIONAL THREATS AND
CAPABILITIES
HOUSE ARMED SERVICE
COMMITTEE
UNITED STATES HOUSE OF REPRESENTATIVES
CONCERNING
COUNTERING THE THREAT OF
WEAPONS OF MASS DESTRUCTION TERRORISM
MARCH 19, 2003
Mr. Chairman and Members of
the Committee. I am Brigadier General
Stephen V. Reeves, the Program Executive
Officer for Chemical and Biological
Defense. We are located in Falls Church,
Virginia. I sincerely appreciate this
opportunity to represent the Department of
Defense today, and to provide testimony on
this important subject.
The mission of the Program
Executive Office is to meet the chemical and
biological defense medical and nonmedical
requirements of our warfighters. The
Program Executive Office for Chemical and
Biological Defense executes this mission for
all the armed services through the life
cycle research, development, procurement and
deployment of major end items of Nuclear,
Biological and Chemical defense equipment as
well as chemical and biological defense
medical treatments, vaccines and devices.
Using a focused program management
structure, we maintain continuous and
effective communication with the science and
technology community; the Joint Requirements
Office; our warfighters; industry, technical
and operational testers and independent
evaluators, Service logistics and
sustainment activities, and with the Office
of the Secretary of Defense and the Congress
who have oversight responsibilities. This
focused management approach ensures the
rapid and effective development and fielding
of new capabilities meeting joint service
requirements.
In accordance with law, The
Army is the executive agent for the
Department of Defense’s Chemical and
Biological Defense Program. The
acquisition professionals that lead and make
up our project and product management teams
come from all of the services allowing us to
leverage the very best talent and technical
expertise from each. Collectively, we share
the goal of providing our armed forces the
best chemical and biological defense
medicine and equipment at the right time, at
the right place, and at the right cost.
Today, I would like to show
you just some of the results of the
substantial Congressional support we have
received since Desert Storm and the hard
work by our joint service acquisition
professionals. The equipment I will
highlight is in use in the Gulf region today
protecting our men and women from weapons of
mass destruction and enabling them to
accomplish their mission.
In
summary, we are providing our soldiers,
sailors, airmen and marines the best
technology, training and equipment in the
world.
Again, I sincerely appreciate this
opportunity to testify before the
subcommittee. Subject to your questions,
this concludes my testimony.
